What Happened?
New York, NY-based Nuvation Bio Appointed David Hanley as Chief Technical Operations Officer
About the Company
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio`s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world`s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
About the Person
David Hanley is Chief Technical Operations Officer at Nuvation Bio. Previously, David held various senior IT leadership roles in the industry.
Info Source
News
Short Profile